Metraipolis › archive › dc_ce9ced798574

From Mechanism to Therapy: Isoliquiritigenin as a Novel Anti-Inflammatory Agent for Inflammatory Disease Management — Europe PMC PMID:41863469

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41863469
DOI: 10.2174/0118715303395815250904075148
License (as archived): solo-consultazione
Archived: 2026-11-07T04:17:17.730Z
SHA-256 of the archived text: 7ac10fddd874e82883afe88ede66caf8b7972b9845bc9d4b9167cdda964f9251
Stable URL of this page: https://metraipolis.com/documento/dc_ce9ced798574

How to cite

From Mechanism to Therapy: Isoliquiritigenin as a Novel Anti-Inflammatory Agent for Inflammatory Disease Management — Europe PMC PMID:41863469 — Europe PMC (en), https://europepmc.org/article/MED/41863469 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce9ced798574 (Metraipolis archive dc_ce9ced798574, sha256 7ac10fddd874e82883afe88ede66caf8b7972b9845bc9d4b9167cdda964f9251)

BibTeX

@misc{dcce9ced798574,
  title = {From Mechanism to Therapy: Isoliquiritigenin as a Novel Anti-Inflammatory Agent for Inflammatory Disease Management — Europe PMC PMID:41863469},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41863469},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce9ced798574; sha256 7ac10fddd874e82883afe88ede66caf8b7972b9845bc9d4b9167cdda964f9251},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41863469. Agents can read the archived copy with the MCP tool read_document.